Author

Marta Korjagina

Observed name: Korjagina, Marta

Observed institution: IQVIA (United Kingdom)

OpenAlex ID: A5031646554

Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden

2020 · Katja Marja Hakkarainen, Rosa Juuti, et al. · Therapeutic Advances in Neurological Disorders · 34

Prevalence of adverse pregnancy outcomes after exposure to interferon beta prior to or during pregnancy in women with MS: Stratification by maternal and newborn characteristics in a register-based cohort study in Finland and Sweden

2020 · Marta Korjagina, Katja M Hakkarainen, et al. · Multiple Sclerosis and Related Disorders · 16

Contemporary Practice and Considerations for Real‐World Data Source Identification and Feasibility Assessment

2024 · Dony Patel, Sonia Guleria, et al. · Pharmacoepidemiology and Drug Safety · 6

Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate ( ETIE )—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research

2025 · Enriqueta Vallejo‐Yagüe, Sieta T. de Vries, et al. · Pharmacoepidemiology and Drug Safety · 1

Prevalence of Serious Adverse Pregnancy Outcomes After Exposure to Interferon Beta Before or During Pregnancy: Stratification by Characteristics of Pregnant Women with MS in a Register-based Cohort study in Finland and Sweden (369)

2020 · Marta Korjagina, Katja Hakkarainen, et al. · Neurology

Works count: 6

Citation count: 57

H-index: 3

I10-index: 2